Related Experiment Video

Updated: Jun 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Otitis media: viruses, bacteria, biofilms and vaccines

Helen M Massa1, Allan W Cripps, Deborah Lehmann

  • 1Griffith Health, Griffith University, Gold Coast, QLD, Australia.

The Medical Journal of Australia
|November 4, 2009
PubMed

Insights

Acute otitis media (AOM) and otitis media with effusion (OME) present diagnostic challenges. While antibiotics offer limited benefit for AOM, vaccines are a promising future direction for reducing global otitis media burden.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Pediatrics

Background:

  • Otitis media, including acute otitis media (AOM) and otitis media with effusion (OME), is common in children.
  • Diagnosis can be difficult due to patient age and varied symptoms.
  • Often occurs alongside viral upper respiratory tract infections and bacterial infections.

Purpose of the Study:

  • To review the clinical presentation, causative agents, and current treatment of otitis media.
  • To discuss the challenges in diagnosis and the role of antibiotic therapy.
  • To highlight future directions, particularly vaccine development, for managing otitis media.

Main Methods:

  • Literature review of otitis media epidemiology, etiology, and management.
  • Analysis of the efficacy and limitations of antibiotic therapy.
  • Exploration of vaccine development strategies for otitis media prevention.

Main Results:

  • AOM symptoms include fever and ear pain; OME is often asymptomatic fluid accumulation.
  • Common viral causes include RSV and rhinovirus; bacterial pathogens include Streptococcus pneumoniae.
  • Antibiotics provide minimal benefit for AOM, but prophylaxis can reduce recurrence in high-risk children.
  • High rates of antibiotic use in Australia contribute to antibiotic resistance.

Conclusions:

  • Effective otitis media management requires accurate diagnosis and judicious antibiotic use.
  • Vaccine development targeting multiple pathogens is crucial for long-term reduction of otitis media burden.
  • Ongoing research and monitoring are essential for adapting vaccines to evolving pathogen resistance patterns.

More Related Videos

In vitro Biofilm Formation in an 8-well Chamber Slide06:14

In vitro Biofilm Formation in an 8-well Chamber Slide

Published on: January 20, 2011

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model05:03

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model

Published on: December 14, 2016

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...